DrugPatentWatch Database Preview

Dell Labs Company Profile

« Back to Dashboard

What is the competitive landscape for DELL LABS, and what generic and branded alternatives to DELL LABS drugs are available?

DELL LABS has ten approved drugs.

Summary for Dell Labs

US Patents:	0
Tradenames:	7
Ingredients:	7
NDAs:	10

Drugs and US Patents for Dell Labs

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dell Labs	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	017540-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Dell Labs	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	017540-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Dell Labs	DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate	INJECTABLE;INJECTION	083161-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Dell Labs	LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	083390-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Dell Labs